HomeInsightsMarket Capitalization

Market Capitalization of Alkem Laboratories Ltd

Market Capitalization of Alkem Laboratories Ltd

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 21, 2024)

stocks purchased

1.0 K

Stocks Traded

(Nov 21, 2024)

Last Updated on: Nov 22, 2024

Image

Alkem Laboratories Ltd

NSE: ALKEM

Market Cap

₹ 66992.27 crore

Last updated on: Nov 21, 2024

Key Highlights

  • The Market Cap of Alkem Laboratories Ltd is ₹ 66992 crore as of 21 Nov 24 .
  • The Market Cap of Alkem Laboratories Ltd changed from ₹ 20945 crore on March 2019 to ₹ 59067 crore on March 2024 . This represents a CAGR of 18.86% over 6 years.
  • The Latest Trading Price of Alkem Laboratories Ltd is ₹ 5603 as of 21 Nov 15:30 .
  • The Dividend Payouts of Alkem Laboratories Ltd changed from ₹ 4 on Aug 08, 2022 to ₹ 5 on Aug 09, 2024 . This represents a CAGR of 3.79% over 6 years.

Historical Market Cap of Alkem Laboratories Ltd

No data available

* All values are in crore

Company Fundamentals for Alkem Laboratories Ltd

No data available

Image

Alkem Laboratories Ltd

NSE: ALKEM

Share Price

₹ 5603

77.75 (1.41%)

stock direction

Last updated on: Nov 21, 2024

Market Price of Alkem Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Alkem Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20245603
19 Nov 20245525.25
18 Nov 20245508.7
14 Nov 20245522.7
13 Nov 20245574.05
12 Nov 20245501.35
11 Nov 20245619.3
08 Nov 20245701.35
07 Nov 20245721.4
06 Nov 20245852.85

SWOT Analysis Of Alkem Laboratories Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alkem Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Alkem Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Alkem Laboratories Ltd

No data available

No data available

Historical P/E Ratio of Alkem Laboratories Ltd

No data available

* All values are in %

Historical Revenue of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Alkem Laboratories Ltd

No data available

* All values are in

About Alkem Laboratories Ltd

  • Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations.
  • The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
  • The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
  • With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales.
  • The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Ltd was incorporated as a private limited company on August 8, 1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988.

Alkem Laboratories Ltd News Hub

News

Alkem Laboratories Ltd eases for fifth straight session

Alkem Laboratories Ltd fell for a fifth straight session today. The stock is quoting at Rs...

Read more

13 Nov 202413:14

News

Alkem Laboratories to conduct board meeting

Alkem Laboratories will hold a meeting of the Board of Directors of the Company on 13 Nove...

Read more

07 Nov 202414:15

News

Alkem Laboratories inks licensing agreement with Sonnet

Alkem Laboratories has entered into a licensing agreement with US-based Sonnet BioTherapeu...

Read more

10 Oct 202418:35

News

Alkem Labs signs licensing agreement with Sonnet BioTherapeutics

SON-080 is Sonnet's proprietary version of 'atexakin alfa'. It has shown encouraging data ...

Read more

10 Oct 202414:53

News

Alkem Laboratories Ltd soars 2.24%

Alkem Laboratories Ltd is up for a third straight session in a row. The stock is quoting a...

Read more

04 Oct 202413:05

News

Alkem Laboratories Ltd rises for third consecutive session

Alkem Laboratories Ltd gained for a third straight session today. The stock is quoting at ...

Read more

05 Sep 202413:05

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Alkem Laboratories Ltd Market Cap

What is the market cap of Alkem Laboratories Ltd?

As of November 22, 2024, Alkem Laboratories Ltd has a market capitalization of ₹66992.27, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Alkem Laboratories Ltd's market capitalization?

Alkem Laboratories Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Alkem Laboratories Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Alkem Laboratories Ltd's market capitalization change?

Alkem Laboratories Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*